Richard Doubleday, EVP Chief Commercial Officer at DEXCOM INC (DXCM), sold 3,062 shares at $410.26 ($1.3M) on 2020-06-23, disclosed to the SEC on 2020-06-25.
Seasonal sale ($1.3M) by EVP Chief Commercial Officer — this insider has traded DXCM in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $407.13 | 355 | $145K | 11.5% |
| 2 | $407.13 | 355 | $145K | 11.5% |
| 3 | $408.90 | 354 | $145K | 11.5% |
| 4 | $408.90 | 354 | $145K | 11.5% |
| 5 | $410.26 | 595 | $244K | 19.5% |
| 6 | $410.26 | 595 |
| $244K |
| 19.5% |
| 7 | $411.54 | 227 | $93K | 7.5% |
| 8 | $411.54 | 227 | $93K | 7.5% |
| Total | $409.41 avg | 3,062 | $1.3M | 100% |
| Filing → |
| DXCM | SELL | 2021-01-25 | $815K | — | Filing → |
| DXCM | SELL | 2021-01-06 | $8.1M | — | Filing → |
| DXCM | SELL | 2020-12-28 | $661K | — | Filing → |